Common Side Effects of Weight Loss Medication in the UK In the UK, weight loss medications are regulated by the Medicines and Healthcare products Regulatory Agency (MHRA), and their side effect profiles are documented in the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL) for each medicine, available via the Electronic Medicines Compendium (EMC)
Anti-Inflammatory Properties: May reduce inflammation in the body, which is beneficial for conditions like arthritis and other inflammatory diseases
A vial used at higher doses will be depleted faster, potentially well within the BUD, while a vial used at lower titration doses may approach the BUD before all doses are drawn
138 However, excessive or chronic inflammation exhausts immune cells due to the constant exposure of T antigens, causing dysfunction with the maintained expression of inhibitory receptors such as PD1 and CTLA4, which alter transcription
Wetterslev J, Jakobsen JC, Gluud C
As stakeholders grapple with shortages and the emergence of compounded alternatives, its crucial to understand the current landscape and its implications for pharmacy benefits management